抗VEGF药物治疗黄斑水肿的研究进展

Advances in treatment of macular edema with VEGF inhibitors

黄斑水肿是临床常见的眼病体征,是多种眼病致盲的主要原因。在治疗原发疾病的同时如何治疗黄斑水肿是人们极为关注的问题。随着抗血管内皮生长因子(VEGF)药物的研发及应用,抗VEGF药物在黄斑水肿治疗中的地位越来越重要,为治疗黄斑水肿开辟了一个崭新的方向。本文介绍了3种抗VEGF药物治疗黄斑水肿的研究进展。

Macular edema is a common clinical disease signs, which is the major cause of blindness for a variety of eye diseases. How to treat macular edema is of great concern with the treatment of primary disease. With the development and application of vascular endothelial growth factor （ VEGF ） inhibitors, anti-VEGF therapy occupy an important position in the treatment of macular edema, and has opened up a new direction for the treatment. This article introduces three kinds of VEGF drugs for the treatment of macular edema research progress.